Drugs / human tissue urokinase type plasminogen activator
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00418275 | Apr 2001 → Jun 2004 | cerebral infarction | Global Biotech | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human tissue urokinase type plasminogen activator | “new thrombolytic agent human tissue urokinase type plasminogen activator (HTUPA)” PMID 16424373 ↗ Jan 2006 |
| Known as | HTUPA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00418275 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant Human Plasminogen Activator (HTUPA)” NCT00418275 ↗ |
| Route | Intravenous | “single bolus intravenous HTUPA” PMID 16424373 ↗ Jan 2006 |